Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients. Issue 5 (15th April 2020) - Dalla Palma, Benedetta; Accardi, Fabrizio; Prezioso, Lucia; Notarfranchi, Laura; Giuliani, Nicola